These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36383081)

  • 1. Electroencephalogram inability to detect intraoperative awakening in a patient with remimazolam tolerance.
    Kawashima S; Kinoshita H; Kawashima W; Nakajima Y
    Minerva Anestesiol; 2023 May; 89(5):482-483. PubMed ID: 36383081
    [No Abstract]   [Full Text] [Related]  

  • 2. A miniature pig model of pharmacological tolerance to long-term sedation with the intravenous benzodiazepines; midazolam and remimazolam.
    Io T; Saunders R; Pesic M; Petersen KU; Stoehr T
    Eur J Pharmacol; 2021 Apr; 896():173886. PubMed ID: 33493482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance to remimazolam at a high effect-site concentration.
    Kida K; Taguchi M; Uchiyama K; Fujioka S; Tsubokawa T
    J Anesth; 2023 Feb; 37(1):168-169. PubMed ID: 36449088
    [No Abstract]   [Full Text] [Related]  

  • 4. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.
    Rex DK; Bhandari R; Desta T; DeMicco MP; Schaeffer C; Etzkorn K; Barish CF; Pruitt R; Cash BD; Quirk D; Tiongco F; Sullivan S; Bernstein D
    Gastrointest Endosc; 2018 Sep; 88(3):427-437.e6. PubMed ID: 29723512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What May Be the First Phase 4 Experience with BYFAVO (Remimazolam).
    Henson KS; Thompson KJ
    AANA J; 2021 Apr; 89(2):101-102. PubMed ID: 33832568
    [No Abstract]   [Full Text] [Related]  

  • 8. Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies.
    Pedersen MH; Danø A; Englev E; Kattenhøj L; Munk E
    Curr Med Res Opin; 2023 May; 39(5):691-699. PubMed ID: 36999319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Arrest Following Remimazolam-Induced Anaphylaxis: A Case Report.
    Hasushita Y; Nagao M; Miyazawa Y; Yunoki K; Mima H
    A A Pract; 2022 Sep; 16(9):e01616. PubMed ID: 36149988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sedation outcomes for remimazolam, a new benzodiazepine.
    Oka S; Satomi H; Sekino R; Taguchi K; Kajiwara M; Oi Y; Kobayashi R
    J Oral Sci; 2021 Jun; 63(3):209-211. PubMed ID: 34092775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remimazolam for anaesthesia or sedation.
    Sneyd JR; Rigby-Jones AE
    Curr Opin Anaesthesiol; 2020 Aug; 33(4):506-511. PubMed ID: 32530890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During Bronchoscopy.
    Pastis NJ; Yarmus LB; Schippers F; Ostroff R; Chen A; Akulian J; Wahidi M; Shojaee S; Tanner NT; Callahan SP; Feldman G; Lorch DG; Ndukwu I; Pritchett MA; Silvestri GA;
    Chest; 2019 Jan; 155(1):137-146. PubMed ID: 30292760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awaiting remimazolam guidance.
    Wootton J; Forrest M
    Br Dent J; 2023 Jan; 234(2):73. PubMed ID: 36707554
    [No Abstract]   [Full Text] [Related]  

  • 14. Remimazolam should be antagonized by an adequate flumazenil.
    Sato T; Nishiwaki K
    J Anesth; 2023 Feb; 37(1):164-165. PubMed ID: 36197518
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys.
    Kops MS; Pesic M; Petersen KU; Schmalix WA; Stöhr T
    Eur J Pharmacol; 2021 Jan; 890():173639. PubMed ID: 33065095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency and safety of remimazolam and midazolam in digestive endoscopic sedation: Systematic review and meta-analysis.
    Dou D; Feng Y; Jiang L
    Dig Endosc; 2022 Mar; 34(3):653. PubMed ID: 34918386
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial.
    Doi M; Morita K; Takeda J; Sakamoto A; Yamakage M; Suzuki T
    J Anesth; 2020 Aug; 34(4):543-553. PubMed ID: 32417976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological sedative indicators during general anesthesia with remimazolam.
    Shirozu K; Nobukuni K; Tsumura S; Imura K; Nakashima K; Takamori S; Higashi M; Yamaura K
    J Anesth; 2022 Apr; 36(2):194-200. PubMed ID: 34999964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy.
    Borkett KM; Riff DS; Schwartz HI; Winkle PJ; Pambianco DJ; Lees JP; Wilhelm-Ogunbiyi K
    Anesth Analg; 2015 Apr; 120(4):771-80. PubMed ID: 25502841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the amount of flumazenil needed to antagonize remimazolam.
    Aya D; Hoshi T; Yamaguchi H
    Eur J Gastroenterol Hepatol; 2021 Oct; 33(10):1335-1336. PubMed ID: 34581692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.